Supplier Type
- Reagent
- Manufacturer
- Trader
- contract manufacturer
- custom synthesis
Supplier Region
- Mumbai(15)
- Hyderabad(10)
- Pune(2)
- Maharashtra(6)
- Delhi(2)
- Gujarat(5)
- Karnataka(1)
- Andhra Pradesh(1)
- Vadodara(4)
- Ahmedabad(3)
- Nagpur(1)
- Kolkata(1)
- Punjab(1)
Purity
- Salicylic Acid
- Rasagiline Mesylate Impurity C
- Pure
- NLT95%
- NLT 95%
- NLT 90%
- more than 95%
- more than 90%
- Mesalazine EP Impurity H
- Mathadone (M225865) impurity. Used in synthesis of methadone, antispasmodics and other pharmaceutica
- Greater than 99%
- Empagliflozin intermediate, Dapagliflozin Impurity
- Dipropargyl r- amino indane
- Dapagliflozin Intermediate, Dapagliflozin Impurity
- API Impurity / In-house working standard
- Acetylsalicylic Acid EP Impurity C
- 99.99%
- 99.98%
- 99.95%
- 99.91%
- 99.86%
- 99.85%
- 99.73%
- 99.42%
- 99.29%
- >99.0% (HPLC,T)
- 99%
- 98+
- 98.60%
- 98.12%
- 98%
- 97-99%
- 97-99 %
- 97.57%
- 97%
- 97 %
- 96.80%
- 96.39%
- 96.14%
- 96%
- 95-98%
- 95.48%
- >95.0%(T)
- 95%
- >95%
- 93-98%
- >92%
- 90%
- >90%
- 25 MG 50 MG 100 MG 250 MG EXTRA
- 100%
- (R)-N,N-di(prop-2-yn-1-yl)-2,3- dihydro-1
Package
- 2.5501e+00925 MG 50 MG 100 MG 250 MG EXTRA
- 2.5501e+00925 MG 50 MG 100 MG 250 MG EXTRA
- 25MG
- 1g
- 5g
- 25g
- 1kg
- 5kg
- 10kg
- 25kg
- 50kg
- 100kg
- 250kg
- 1MT
- 95NLT %
-
Tofacitinib Impurity J
-
1-(4-(2-Hydroxy-3-(isopropylaMino)propoxy)phenyl)-2-Methoxyethanone
73723-85-0
-
4-[[3-(1-Methylethyl)-2-oxo-5-oxazolidinyl]methoxy]benzaldehyde
1173203-26-3
-
MS Bucket Tooth Point
-
ERYTHROMYCIN IMPURITY N
-
L 683519
132172-14-6
-
3'-Demethyl-12-deoxyerythromycin
33442-56-7
-
AzithroMycin IMpurity C
-
1-Hydroxyibuprofen
53949-53-4
-
1-(Triphenylmethyl)imidazole
15469-97-3
Ethyl (Z)-2- 2-aminothiazol-4-yl)-2-(1-t- butoxycarb nyl-1 methyl)ethoxyiminoacetate 86299-46-9
Creative Engineers Square T Slot aluminum extrusion profile, Size: From 20*20 To 90*90
GB/T 22CR12NIWMOV Stainless Steel Round Bar, UNS S47220 Rods, GB/T 22CR12NIWMOV Bars, Blank, Rings
Diphenyl Acetonitrile, C14H11N, Cas Number: 86-29-3 86-29-3
Tofacitinib citrate 540737-29-9










